To announce the ex-rights and dividend record date
and the closure period for the conversion of CB4 and CB5
Date of events
2022/08/11
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or
shareholders' meeting, or of the decision by the company:2022/08/11
2.Type (ex-rights or ex-dividend) (please write "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-rights and dividend
3.Type and monetary amount of dividend distribution:
(1)Appropriations of earnings in cash dividends:NT$ 1,262,621,868
(NT$2.5 per share)
(2)Appropriations of earnings in stock dividends:NT$ 757,573,120
(150 shares for each 1,000 shares)
4.Ex-rights (Ex-dividend) date:2022/09/08
5.Last date before book closure:2022/09/12
6.Book closure starting date:2022/09/13
7.Book closure ending date:2022/09/17
8.Ex-rights (Ex-dividend) record date:2022/09/17
9.Deadline for applying the conversion of the debt voucher:2022/08/18
10.The closure period for the conversion of the debt voucher will
start from the date:2022/08/22
11.The closure period for the conversion of the debt voucher will
end on the date: 2022/09/17
12.Payment date of cash dividend distribution:2022/10/14
13.Any other matters that need to be specified:
If the number of shares outstanding has changed,the cash and stock
dividends ratio must be adjusted. The shareholders' meeting fully
authorizes the chairman of the Board of Directors to adjust the
dividend ratio.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Center Laboratories Inc. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 09:40:08 UTC.
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
CENTER LABORATORIES, INC. 
